Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment

被引:4
|
作者
Kuo, Yu-Chi [1 ]
Wang, Shang-Yu [1 ,2 ,3 ]
Hung, Yu-Liang [1 ]
Hsu, Chih-Chieh [1 ]
Kou, Hao-Wei [1 ]
Chen, Ming-Yang [1 ]
Tsai, Chun-Yi [1 ]
Chang, Chih-Hsiang [3 ,4 ]
Wang, Yu-Chao [1 ]
Hsu, Jun-Te [1 ,3 ]
Yeh, Ta-Sen [1 ,3 ]
Lee, Wei-Chen [1 ,3 ]
Yeh, Chun-Nan [1 ,3 ]
机构
[1] Linkou Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Taoyuan City, Taiwan
[2] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan City, Taiwan
[3] Chang Gung Univ, Coll Med, Taoyuan City, Taiwan
[4] Linkou Chang Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Taoyuan City, Taiwan
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
secondary hyperparathyroidism; parathyroidectomy; end-stage renal disease; recurrence; parathyroid; JAPANESE HEMODIALYSIS-PATIENTS; TOTAL PARATHYROIDECTOMY; RENAL-DISEASE; AUTOTRANSPLANTATION; MANAGEMENT; CINACALCET; PTH;
D O I
10.3389/fendo.2023.1063837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundSecondary hyperparathyroidism (SHPT) is a common condition in patients with end-stage renal disease (ESRD) who are on dialysis. Parathyroidectomy is a treatment for patients when medical therapy has failed. Recurrence may occur and is indicated for further surgery in the era of improved quality of care for ESRD patients. MethodsWe identified, 1060 patients undergoing parathyroidectomy from January, 2011 to June, 2020. After excluding patients without regular check-up at our institute, primary hyperparathyroidism, or malignancy, 504 patients were enrolled. Sixty-two patients (12.3%, 62/504) were then excluded due to persistent SHPT even after the first parathyroidectomy. We aimed to identify risk factors for recurrent SHPT after the first surgery. ResultsDuring the study period, 20% of patients who underwent parathyroidectomy at our institute (in, 2019) was due to recurrence after a previous parathyroidectomy. There were 442 patients eligible for analysis of recurrence after excluding patients with the persistent disease (n = 62). While 44 patients (9.95%) had recurrence, 398 patients did not. Significant risk factors for recurrent SHPT within 5 years after the first parathyroidectomy, including dialysis start time to first operation time < 3 years (p = 0.046), postoperative PTH >106.5 pg/mL (p < 0.001), and postoperative phosphorus> 5.9 mg/dL (p = 0.016), were identified by multivariate analysis. ConclusionsThe starting time of dialysis to first operation time < 3 years in the patients with dialysis, postoperative PTH> 106.5 pg/mL, and postoperative phosphorus> 5.9 mg/dL tended to have a higher risk for recurrent SHPT within 5 years after primary treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Risk factors for treatment failure in surgery for primary hyperparathyroidism: the impact of change in surgical strategy and training procedures
    Anders Rørbæk Madsen
    Lars Rasmussen
    Christian Godballe
    European Archives of Oto-Rhino-Laryngology, 2016, 273 : 1599 - 1605
  • [32] Calcimimetics and the treatment of primary and secondary hyperparathyroidism
    Joy, MS
    Kshirsagar, AV
    Franceschini, N
    ANNALS OF PHARMACOTHERAPY, 2004, 38 (11) : 1871 - 1880
  • [33] Risk factors of hyperkalemia after total parathyroidectomy in patients with secondary hyperparathyroidism
    Zou, Yun
    Zhang, Liwei
    Zhou, Hua
    Yang, Yan
    Yang, Min
    Di, Jia
    RENAL FAILURE, 2020, 42 (01) : 1029 - 1031
  • [34] SURGICAL-TREATMENT OF PRIMARY HYPERPARATHYROIDISM
    SARFATI, E
    CASANOVA, D
    DUBOST, C
    ANNALES D ENDOCRINOLOGIE, 1994, 55 (05) : 165 - 170
  • [35] SURGICAL-TREATMENT OF PRIMARY HYPERPARATHYROIDISM
    BRASSO, K
    KARSTRUP, S
    LUNDBY, CM
    KRISTENSEN, LO
    HOLM, HH
    DANISH MEDICAL BULLETIN, 1994, 41 (05): : 585 - 588
  • [36] SURGICAL-TREATMENT OF PRIMARY HYPERPARATHYROIDISM
    ALAOUI, M
    ALMOU, M
    BENAGUIDA, M
    FAROUQUI, A
    ELALAOUI, M
    MANSOURI, A
    ACTA CHIRURGICA BELGICA, 1990, (03) : 102 - 105
  • [37] SURGICAL-TREATMENT OF PRIMARY HYPERPARATHYROIDISM
    GLOCK, Y
    GAILLARD, J
    BERTHOUMIEU, F
    BOUISSOU, H
    DURROUX, R
    ESCHAPASSE, H
    REVUE DE MEDECINE DE TOULOUSE, 1980, 16 (10): : 559 - &
  • [38] Insulin sensitivity in pateints with primary hyperparathyroidism before and after surgical treatment
    Micic, D.
    Cvijovic, G.
    Kendereski, A.
    Sumarac-Dumanovic, M.
    Zoric, S.
    Pejkovic, D.
    Cubrilo, K.
    Georgiev, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 361 - 361
  • [39] RISK FACTORS FOR ERYSIPELAS AFTER PRIMARY SURGICAL TREATMENT IN PATIENTS WITH VULVAR CARCINOMA
    Leermakers, M. E. J.
    Pleunis, N.
    Wieringa, M. H.
    van der Wurff, A.
    Klinkhamer, P.
    Boll, D.
    Hermans, R. H.
    Ezendam, N. P. M.
    Pijnenborg, J. M. A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [40] Recent Trends in the Surgical Treatment of Secondary Hyperparathyroidism
    Won, Ho-Ryun
    Koo, Bon Seok
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2020, 13 (02) : 91 - 92